MXCT compared with SKIN: revenue, margins and what each company keeps, and the suppliers and customers both name

MXCTMaxcyte, Inc.

Mkt capRevenueRevenue

SKINSkinHealth Systems Inc.

Mkt capRevenueRevenue

Compare

MXCTMaxcyte, Inc.

SKINSkinHealth Systems Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

MXCT

0 of 3at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±81.8%▲+9.45%×0.11

May 13 '26±90.0%▲+24.06%×0.27

Q1 FY26—▼−6.81%—

Jan 13 '26±65.8%▼−3.68%×0.06

SKIN1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±33.5%▼−13.91%×0.41

= impliedMXCT realized, solidSKIN realized, hatchedOne scale, both sides: full bar = 90%× = |realized| ÷ impliedSource: market data

MXCTMaxcyte, Inc.

1.57▼−9.25%· post 1.57

Mkt cap$164.1MRevenue$7MQ2 FY26Revenue$33MFY25

SKINSkinHealth Systems Inc.

9.96▼−1.83%· post 9.96

ClosedOct 30 '26

Mkt cap$64.7MRevenue$72MQ2 FY26Revenue$301MFY25

Compare

ClosedOct 30 '26

MXCTMaxcyte, Inc.

SKINSkinHealth Systems Inc.

1.57▼−9.25%post 1.57

Price

9.96▼−1.83%post 9.96

$164.1M

Mkt cap

$64.7M

Q2 FY26$7M

Revenue

$72MQ2 FY26

FY25$33M

Revenue

$301MFY25

MXCT1.57▼−9.25%vsSKIN9.96▼−1.83%ClosedOct 30 '26